Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Therapeutics, Inc. Attovia currently holds 538,300 shares of Attovia Therapeutics, Inc. (ATTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Therapeutics, Inc. Attovia has been a net neutral trader of ATTO stock. They have purchased $0 and sold $0 worth of shares.
Therapeutics, Inc. Attovia's most recent insider trade was on Aug 4, 2026, when they sold 538,300 shares at $0.00 per share.
Therapeutics, Inc. Attovia serves as Executive at Attovia Therapeutics, Inc. (ATTO). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Therapeutics, Inc. Attovia holds the position of Executive at Attovia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Therapeutics, Inc. Attovia has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Therapeutics, Inc. Attovia was on Aug 4, 2026, when they purchased $0 worth of ATTO shares. This transaction involved 538,300 shares at N/A per share.
Therapeutics, Inc. Attovia currently owns 538,300 shares of Attovia Therapeutics, Inc. (ATTO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Therapeutics, Inc. Attovia's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Therapeutics, Inc. Attovia has 2 Form 4 filings on record as an insider at Attovia Therapeutics, Inc..
Set alerts for Therapeutics, Inc. Attovia and 40,000+ other insiders.